Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | LAP3 | P28838 | 3/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.45 |
| ▸ | MME | P08473 | 5/20 | 0.44 |
| ▸ | CTSC | P53634 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18613505 | 1.00 | ALDH1A1 (0.53) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL1674750 | 1.00 | ALDH1A1 (0.53) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL29425348 | 0.95 | ALDH1A1 (0.49) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL30974405 | 0.93 | MME (0.48) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL29663577 | 0.90 | ALDH1A1 (0.44) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL30808873 | 0.90 | ALDH1A1 (0.46) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL6367814 | 0.89 | OPRM1 (0.44) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL6367826 | 0.89 | OPRM1 (0.44) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL31289517 | 0.88 | MME (0.48) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL3873046 | 0.88 | ALDH1A1 (0.45) | ALDH1A1MEN1LMNAKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 8130 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119736362-A | Preparation method and application of spirulina polypeptide | 无限极（中国）有限公司 | 2025-04-01 | — | — | CN | claimed |
| CN-119524104-A | Liver-protecting polypeptide preparation and preparation method thereof | 陕西语泽生物医药有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-118812629-A | Preparation method of pecan protein peptide and beverage thereof | 无锡爱科派生物科技有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-116478235-A | Ham flavor peptide and preparation method thereof | 昆明理工大学 | 2023-07-25 | — | — | CN | claimed |
| WO-2022256800-A2 | HUMAN SPERMINE OXIDASE CRYSTAL AND USES THEREOF | JANSSEN VACCINES & PREVENTION B.V. (NL) | 2022-12-08 | — | — | WO | claimed |
| CN-103597071-A | Chemosensory receptor ligand-based therapies | ELCELYX THERAPEUTICS INC | 2014-02-19 | — | — | CN | claimed |
| EP-2661266-A2 | CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES | Elcelyx Therapeutics, Inc. (US) | 2013-11-13 | — | — | EP | claimed |
| WO-2012094636-A2 | CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES | ELCELYX THERAPEUTICS, INC. (US) | 2012-07-12 | — | — | WO | claimed |
| CN-116348115-B | Combination of antibody-drug conjugate and PARP1 selective inhibitor | ASTRAZENECA UK LTD. (GB) | 2026-05-26 | — | — | CN | disclosed |
| CN-116410307-B | Neutralizing antibody for neutralizing SARS-CoV-2 in six strains and its application | TSINGHUA UNIVERSITY (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-114080232-B | Extracellular vesicles for vaccine delivery | Lhasa Sales Co.,Ltd. (CH) | 2026-05-26 | — | — | CN | disclosed |
| CN-115038722-B | Antibodies against KLK5 | UCB biopharmaceutical Co.,Ltd. (BE) | 2026-05-26 | — | — | CN | disclosed |
| CN-122080238-A | RBoNT recombinant protein and precursor thereof, and preparation method and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| CN-108290931-B | Novel polypeptides having affinity for PD-L1 | AFFIBODY AB (SE) | 2026-05-26 | — | — | CN | disclosed |
| US-7919236-B2 | G-proteins | GIVAUDAN SA (CH) | 2011-04-05 | — | — | US | disclosed |
| EP-1581555-B1 | CHIMERIC ALPHA Q-GUSTDUCIN G-PROTEINS | GIVAUDAN SA (CH) | 2008-04-30 | — | — | EP | disclosed |
| US-20060275765-A1 | G-proteins | GIVAUDAN SA (CH) | 2006-12-07 | — | — | US | disclosed |
| CN-1726224-A | Chimeric alpha Q-gustducin G-proteins | GIVAUDAN SA (CH) | 2006-01-25 | — | — | CN | disclosed |
| EP-1581555-A2 | G-PROTEINS | Givaudan SA (CH) | 2005-10-05 | — | — | EP | disclosed |
| WO-2004055048-A2 | CHIMERIC ALPHA Q-GUSTDUCIN G-PROTEINS | GIVAUDAN SA (CH) | 2004-07-01 | — | — | WO | disclosed |